Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Unnotable thanks for posting....are you a shareholder here?
View:
Post by HarryCallahan45 on Aug 05, 2021 9:03pm

Unnotable thanks for posting....are you a shareholder here?

Sadly i have a large position that i may begin to unwind for exactly the reasons you have articulated....NO INSIDER OWNERSHIP.   None of the usual pumpers here have been able to articulate a reason why that is.  If we are about to "upend" cancer treatment...wouldnt those in the know be buying with both hands????  No one can answer....
Comment by JohnnyYeg on Aug 05, 2021 10:44pm
No insider ownership? As in zero shares owned by managment nor the board of directors? Really?
Comment by unNoteable on Aug 06, 2021 6:22am
As in purchased on the open market. When James Mullen took over as CEO at EDITAS, he purchased 1 million shares at $46 a share... the price subsequently hit the low 30's, but what his action established was a sense of security. If the CEO is prepared to invest a higher price than the price dropped to, then that sets some kind of floor. The price is now in the mid 50's by the way. ONCY ...more  
Comment by unNoteable on Aug 06, 2021 6:43am
Hi Harry, yes, I have a sizeable chunk of my portfolio in ONCY (more fool me). I've seen one too many false dawns, and swallowed the red pill some time ago regarding this investment. When you get emotionally attached to a stock, you end up seeing what you want to. It's not so much that my stock is at a modest loss (I averaged down), but it's the opportunity cost of not having invested ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities